India to gift two million doses of Covishield COVID-19 vaccine to Bangladesh


India will gift Bangladesh two million doses of Covishield Indian vaccine produced by Serum Institute of India on January 20. Covishield is an Oxford-AstraZeneca vaccine and the gifted consignment will arrive at Hazrat Shahjalal International Airport Dhaka.

This is in the final planning stages even certain preparations have started in Dhaka. Bangladesh’s Director-General of the Department of Health, Prof. Abul Bashar Mohammad Khurshid Alam confirmed the development to WION.

Bangladesh’s health minister Zahid Maleque speaking at a press conference earlier today in Dhaka said, “Indian government will send some Covid vaccines to Bangladesh as a gift.”

This will be followed by the start of commercial supplies. The first commercial shipment will reach the country by January 25. In November of last year, Beximco Pharmaceuticals, Bangladesh’s biggest pharma company, the Bangladesh government and Serum Institute of India signed a tripartite agreement to buy 30 million doses of Covishield Covid vaccine.

Under the agreement, the Bangladeshi govt will pay SII for the 30 million doses of the vaccine and Beximco Pharma will receive a separate fee for its distribution role.

Beximco Pharma is the exclusive distributor of the vaccine in Bangladesh and will be responsible for maintaining the cold chain, import, storage, and delivery of the vaccine.

The development comes even as India on Saturday began its mega all India vaccination programme. Last year, during foreign secretary Harsh Shringla’s Bangladesh visit he had assured that when it comes to COVID vaccine, Bangladesh will be a priority under New Delhi’s Neighborhood first policy.


Source: Latest News by www.dnaindia.com.

*The article has been translated based on the content of Latest News by www.dnaindia.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!